Therefore, blockade of one of the IL-15 receptor subunits (CD122) [27] has been tested in murine models of vitiligo with a specific monoclonal antibody, leading to a decrease in short-term effector function of TRM cells through a reduction in IFNγ production, resulting in significant repigmentation in the group of mice treated. Here, IFNG is linked to vitiligo.